MANILA, Philippines — World No. 2 Iga Swiatek has accepted a one-month suspension after testing positive for a banned substance, the International Tennis Integrity Agency (ITIA) announced Thursday.
Swiatek, 23, tested positive for the heart medication trimetazidine (TMZ) in an out-of-competition sample in August 2024 when the Polish player was ranked No. 1 in the world.
The ITIA, however, accepted that it was caused by “the contamination of a regulated non-prescription medication (melatonin), manufactured and sold in Poland that the player had been taking for jet lag and sleep issues.”